Based on initial findings, targeting the inhibition of NLRP3-mediated pyroptosis could potentially be a crucial approach for alleviating ALI [10]. Using pyroptosis inhibition as a clinical prevention or treatment for ALI and ARDS may hold promise in the future. This evidence concerns the gene NLRP3 and acute respiratory distress syndrome.